Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
- Citation:
- JAMA vol 317 (23) 2392-401
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA180799, CA180820, CA180826, U10CA032291, U10CA041287, U10CA047559, U10CA077597, U10CA077651, U10CA077658, U10CA138561, U10CA180790, U10CA180791, U10CA180795, U10CA180830, U10CA180836, U10CA180838, U10CA180850, U10CA180867, U10CA180888, R01 CA149222, U10 CA180821, U10 CA180795, U10 CA180836, U10 CA180791, U10 CA180850, U10 CA180790, U10 CA180882, U10 CA180820, U10 CA180799, U10 CA180867, U10 CA180838, U10 CA180888, U10 CA180830
- Corr. Author:
- Authors:
- Alan P. Venook Donna Niedzwiecki Heinz-Josef Lenz Federico Innocenti Briant Fruth Jeffrey A. Meyerhardt Deborah Schrag Claire Greene Bert H. O'Neil James Norman Atkins Scott Berry Blase N. Polite Eileen M. O'Reilly Richard M. Goldberg Howard S. Hochster Richard L. Schilsky Monica M. Bertagnolli Anthony B. El-Khoueiry Peter Watson Al B. Benson Daniel L. Mulkerin Robert J. Mayer Charles Blanke
- Networks:
- CA011, CA136, LAPS-IL036, LAPS-IL057, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-WI020, NC002, NC012, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article